| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $1.16B | +24.6% |
| Cost of Revenue | $222.9M | +28.9% |
| Gross Profit | $935.6M | +23.7% |
| R&D Expense | $218.3M | +39.7% |
| SG&A Expense | $150.0M | +18.5% |
| Operating Income | $92.8M | +14.1% |
| Interest Expense | $3.4M | -67.2% |
| Pre-tax Income | $90.0M | +25.5% |
| Income Tax | -$18.0M |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $555.3M | +20.0% |
| Accounts Receivable | $442.5M | +26.2% |
| Current Assets | $1.12B | +17.9% |
| Total Assets | $2.77B | +8.8% |
| Current Liabilities | $1.04B | +19.8% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $1.16B | -6.2% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $354.9M | +41.4% |
| Capital Expenditures | $21.5M | +21.7% |
| Investing Cash Flow | -$21.5M | +30.3% |
| Financing Cash Flow | -$232.3M | -188.0% |
| Free Cash Flow | $333.3M | +42.9% |
| -193.7% |
| Net Income | $108.0M | +105.8% |
| EPS (Basic) | $0.38 | +111.1% |
| EPS (Diluted) | $0.37 | +105.6% |
| Stockholders' Equity |
| $1.60B |
| +23.0% |